Publication | Closed Access

Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)

Genitourinary CancerMedicinePreliminary ResultsPathologyPhase Ii StudyThymic Epithelial TumorsCancer TreatmentOncologyRadiation OncologyCancer Research